1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung CancerAdvanced or Metastatic ROS1-Positive Non-Small Cell Lung CancerActive, not recruitingPhase 22026-05-19NCT05297890